Cargando…

Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial

INTRODUCTION: The APROVE-trial investigated the tolerability of postoperative proton beam therapy in women with cervical or endometrial cancer. The present analysis evaluated the secondary endpoints of health-related quality of life (HRQOL) and patient-reported symptoms. METHODS: 25 patients were in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meixner, Eva, Wark, Antje, Forster, Tobias, Weykamp, Fabian, Lang, Kristin, König, Laila, Lindel, Katja, Oelmann-Avendano, Jan Tobias, Krisam, Johannes, Schneeweiss, Andreas, Ellerbrock, Malte, Mielke, Thomas, Hörner-Rieber, Juliane, Herfarth, Klaus, Debus, Jürgen, Arians, Nathalie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827629/ https://www.ncbi.nlm.nih.gov/pubmed/36624483 http://dx.doi.org/10.1186/s13014-023-02198-4

Ejemplares similares

Prospective phase-II-study evaluating postoperative radiotherapy of cervical and endometrial cancer patients using protons – the APROVE-trial
por: Arians, N., et al.
Publicado: (2017)

Evaluation of Uterine Brachytherapy as Primary Treatment Option for Elderly Patients with Medically Inoperable Endometrial Cancer—A Single-Center Experience and Review of the Literature
por: Arians, Nathalie, et al.
Publicado: (2020)

Second breast conserving therapy after ipsilateral breast tumor recurrence – a 10-year experience of re-irradiation
por: Forster, Tobias, et al.
Publicado: (2019)

Validation of Nine Different Prognostic Grading Indexes for Radiosurgery of Brain Metastases in Breast Cancer Patients and Development of an All-Encompassing Prognostic Tool
por: Weykamp, Fabian, et al.
Publicado: (2020)

Palliative Radiotherapy for Symptomatic Locally Advanced Breast Cancer
por: Hoeltgen, Line, et al.
Publicado: (2023)

Adjuvant Radiation Therapy for Male Breast Cancer—A Rare Indication?
por: Forster, Tobias, et al.
Publicado: (2020)

Age-Dependent Hematologic Toxicity Profiles and Prognostic Serologic Markers in Postoperative Radiochemotherapy Treatment for Uterine Cervical Cancer
por: Meixner, Eva, et al.
Publicado: (2022)

Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
por: Weykamp, Fabian, et al.
Publicado: (2020)

Postoperative Radiotherapy for Endometrial Cancer in Elderly (≥80 Years) Patients: Oncologic Outcomes, Toxicity, and Validation of Prognostic Scores
por: Meixner, Eva, et al.
Publicado: (2021)

Secondary Malignancy Risk Following Proton vs. X-ray Treatment of Mediastinal Malignant Lymphoma: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk
por: König, Laila, et al.
Publicado: (2020)

Oncological outcome and recurrence pattern analysis after involved-field irradiation in combination with rituximab for early-stage nodal and extranodal follicular lymphoma
por: König, Laila, et al.
Publicado: (2020)

CERN's biggest contributor aproves new laboratory
por: CERN Press Office. Geneva
Publicado: (1968)

Return to Work, Fatigue and Cancer Rehabilitation after Curative Radiotherapy and Radiochemotherapy for Pelvic Gynecologic Cancer
por: Meixner, Eva, et al.
Publicado: (2022)

Vaginal cancer treated with curative radiotherapy with or without concomitant chemotherapy: oncologic outcomes and prognostic factors
por: Meixner, Eva, et al.
Publicado: (2021)

Methods of Esthetic Assessment after Adjuvant Whole-Breast Radiotherapy in Breast Cancer Patients: Evaluation of the BCCT.core Software and Patients’ and Physicians’ Assessment from the Randomized IMRT-MC2 Trial
por: Forster, Tobias, et al.
Publicado: (2022)

Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
por: Eichkorn, Tanja, et al.
Publicado: (2021)

Long-Term Clinical Results of MR-Guided Stereotactic Body Radiotherapy of Liver Metastases
por: Weykamp, Fabian, et al.
Publicado: (2023)

Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases
por: Weykamp, Fabian, et al.
Publicado: (2022)

Effectiveness and Toxicity of Fractionated Proton Beam Radiotherapy for Cranial Nerve Schwannoma Unsuitable for Stereotactic Radiosurgery
por: Eichkorn, Tanja, et al.
Publicado: (2021)

Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk
por: Hoegen, Philipp, et al.
Publicado: (2022)

Secondary Malignancy Risk Following Proton vs. X-ray Radiotherapy of Thymic Epithelial Tumors: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk
por: König, Laila, et al.
Publicado: (2022)

Intrafractional vaginal dilation in anal cancer patients undergoing pelvic radiotherapy (DILANA) – a prospective, randomized, 2-armed phase-II-trial
por: Arians, Nathalie, et al.
Publicado: (2020)

Adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer FIGO stage III: final results of a prospective phase 2 study
por: Arians, Nathalie, et al.
Publicado: (2019)

Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3
por: Eichkorn, Tanja, et al.
Publicado: (2023)

Percutaneous Parametrial Dose Escalation in Women with Advanced Cervical Cancer: Feasibility and Efficacy in Relation To Long-term Quality of Life
por: Akbaba, Sati, et al.
Publicado: (2018)

Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer
por: Krug, David, et al.
Publicado: (2020)

Fatigue following radiotherapy of low-risk early breast cancer – a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419)
por: Forster, Tobias, et al.
Publicado: (2020)

Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Tumors: Initial Clinical Experience and Patient-Reported Outcomes
por: Weykamp, Fabian, et al.
Publicado: (2021)

Active-Scanned Protons and Carbon Ions in Cancer Treatment of Patients With Cardiac Implantable Electronic Devices: Experience of a Single Institution
por: Seidensaal, Katharina, et al.
Publicado: (2019)

Stereotactic body radiotherapy of lymph node metastases under MR-guidance: First clinical results and patient-reported outcomes
por: Weykamp, Fabian, et al.
Publicado: (2021)

Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients
por: König, Laila, et al.
Publicado: (2020)

Bimodality treatment of patients with pelvic adenoid cystic carcinoma with photon intensity-modulated radiotherapy plus carbon ion boost: a case series
por: Bernhardt, Denise, et al.
Publicado: (2018)

Management of initial and recurrent radiation-induced contrast enhancements following radiotherapy for brain metastases: Clinical and radiological impact of bevacizumab and corticosteroids
por: Meixner, Eva, et al.
Publicado: (2023)

Cone-Beam-CT Guided Adaptive Radiotherapy for Locally Advanced Non-small Cell Lung Cancer Enables Quality Assurance and Superior Sparing of Healthy Lung
por: Hoegen, Philipp, et al.
Publicado: (2020)

Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy
por: Fink, Christoph A., et al.
Publicado: (2023)

Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations
por: Regnery, Sebastian, et al.
Publicado: (2022)

Treatment Outcome of a Combined Dose-Escalated Treatment Regime With Helical TomoTherapy® and Active Raster-Scanning Carbon Ion Boost for Adenocarcinomas of the Head and Neck
por: Akbaba, Sati, et al.
Publicado: (2019)

Outcome after Radiotherapy for Vestibular Schwannomas (VS)—Differences in Tumor Control, Symptoms and Quality of Life after Radiotherapy with Photon versus Proton Therapy
por: Küchler, Maike, et al.
Publicado: (2022)

Outcome of patients with local recurrent gynecologic malignancies after resection combined with intraoperative electron radiation therapy (IOERT)
por: Arians, Nathalie, et al.
Publicado: (2016)

Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist’s point of view
por: Foerster, Robert, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uohcf0s447oiuups7iq4ulvrjm